SERUM IMMUNOGLOBULIN CONCENTRATIONS IN PATIENTS FOLLOWING BONE-MARROW TRANSPLANT AND PROPHYLACTIC ADMINISTRATION OF HIGH-DOSE UNSPECIFIC OR NORMAL-DOSE CMV-SPECIFIC IMMUNOGLOBULIN

被引：0
|
作者：
BERGER, C
GRATWOHL, A
DORAN, JE
SCHERZ, R
BAUMGARTNER, C
MORELL, A
BACHMANN, B
SPAETH, PJ
TICHELLI, A
SPECK, B
机构：
来源：
TRANSFUSION MEDICINE 1988 - INFECTIONS, PLASMA PRODUCTS, TRANSPLANTATIONS, ANTIBODIES | 1989年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：112 / 121
页数：10
相关论文
共 50 条
  • [41] High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant
    C Colby
    S Koziol
    SL McAfee
    B Yeap
    TR Spitzer
    Bone Marrow Transplantation, 2002, 29 : 467 - 472
  • [42] ERYTHROPOIETIC ACTIVITY IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    LITTLEWOOD, TJ
    BENTLEY, DP
    CAVILL, I
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 563 - 563
  • [43] ACCELERATION OF BONE-MARROW RECOVERY BY PRETREATMENT WITH CYCLOPHOSPHAMIDE IN PATIENTS RECEIVING HIGH-DOSE MELPHALAN
    HEDLEY, DW
    MILLAR, JL
    MCELWAIN, TJ
    GORDON, MY
    LANCET, 1978, 2 (8097): : 966 - 968
  • [44] HIGH-DOSE CONSOLIDATION WITH LOCAL RADIATION AND BONE-MARROW RESCUE IN PATIENTS WITH ADVANCED NEUROBLASTOMA
    KREMENS, B
    KLINGEBIEL, T
    HERRMANN, F
    BENDERGOTZE, C
    BURDACH, S
    EBELL, W
    FRIEDRICH, W
    KOSCIELNIAK, E
    SCHMID, H
    SIEGERT, W
    SUTTORP, M
    SCHAEFER, UW
    BERTHOLD, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 23 (06): : 470 - 475
  • [45] AUTOLOGOUS BONE-MARROW RESCUE FOLLOWING HIGH-DOSE CHEMOTHERAPY IN THE TREATMENT OF SOLID TUMORS IN CHILDHOOD
    EKERT, H
    ELLIS, WM
    WATERS, KD
    PATHOLOGY, 1980, 12 (02) : 316 - 316
  • [46] HIGH-DOSE AMSA AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AMBT) IN PATIENTS WITH SOLID TUMORS
    ZANDER, A
    SPITZER, G
    LEGHA, S
    DICKE, K
    VELLEKOOP, L
    VERMA, D
    MINNHAAR, G
    SCHELL, F
    BLUMENSCHEIN, G
    BODEY, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 234 - 234
  • [47] DISPOSITION OF HIGH-DOSE BUSULFAN IN PEDIATRIC-PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
    REGAZZI, MB
    LOCATELLI, F
    BUGGIA, I
    BONETTI, F
    ZECCA, M
    PREGNOLATO, M
    QUAGLINI, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (01) : 45 - 52
  • [48] CNS TOXICITY AND HIGH-DOSE BUSULFAN IN 3 PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
    VASTA, S
    SCIME, R
    INDOVINA, A
    MAJOLINO, I
    HAEMATOLOGICA, 1992, 77 (02) : 189 - 189
  • [49] High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant
    Colby, C
    Koziol, S
    McAfee, SL
    Yeap, B
    Spitzer, TR
    BONE MARROW TRANSPLANTATION, 2002, 29 (06) : 467 - 472
  • [50] STREPTOCOCCAL SEPTICEMIA FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN TREATED WITH HIGH-DOSE CHEMOTHERAPY
    VALTEAU, D
    HARTMANN, O
    BRUGIERES, L
    VASSAL, G
    BENHAMOU, E
    ANDREMONT, A
    KALIFA, C
    LEMERLE, J
    BONE MARROW TRANSPLANTATION, 1991, 7 (06) : 415 - 419
12345